Adaptimmune Therapeutics PLC reports results for the quarter ended in March - Earnings Summary

Adaptimmune Therapeutics

15/05/2024 23:27

* Adaptimmune Therapeutics PLC  ADAP.OQ  reported a
quarterly
adjusted loss of 18 cents​​ per share for the quarter ended in
March, lower than the same quarter last year, when the company
reported EPS of 1 cents.  The mean expectation of five analysts
for the quarter was for a loss of 10 cents per share. Wall
Street expected results to range from -17 cents to -3 cents per
share.
    * Revenue fell 88.1% to $5.68 million from a year ago;
analysts
expected $9.18 million. 
    * Adaptimmune Therapeutics PLC's reported EPS for the
quarter was
a loss of 18 cents​.
    * The company reported a quarterly loss of $48.5 million.
    * Adaptimmune Therapeutics PLC shares had fallen by 27.2%
this
quarter and gained 45.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 28.3%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Adaptimmune
Therapeutics PLC is $2.50 
This summary was machine generated from LSEG data May 15 at
10:26 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.10          -0.18          Missed
 Dec. 31 2023      -0.10          -0.24          Missed
 Sep. 30 2023      -0.14          -0.20          Missed
 Jun. 30 2023      -0.13          -0.23          Missed